Сравнение

Pramlintid vs. VK2735

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Метаболизм

Номер CAS

151126-32-8

нет данных

Молекулярная масса

3949.4 g/mol

нет данных

Период полувыведения

нет данных

Последовательность

нет данных

Механизм действия

Pramlintid

Pramlintide mimics the beta-cell hormone amylin, which is co-secreted with insulin. It slows gastric emptying, suppresses postprandial glucagon release and promotes satiety — thereby blunting post-meal blood-glucose spikes.

VK2735

VK2735 activates both the GLP-1 and the GIP receptor — a dual mechanism similar to that of tirzepatide, suppressing appetite and food intake.

Доказательная база

Наивысшая доказательность

РКИ на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Pramlintid	VK2735
Германия	Не одобрено	Не одобрено
США	Рецептурный	Не одобрено

Полные записи

Frequently asked questions

What is the difference between Pramlintid and VK2735?: Pramlintid is classified as "Метаболизм", while VK2735 is classified as "Метаболизм". Pramlintid: Pramlintide is a synthetic analog of the hormone amylin. It is used as an adjunct to mealtime insulin therapy in type 1 and type 2 diabetes and, among other things, slows gastric emptying. VK2735: VK2735 is a dual GLP-1/GIP receptor agonist from Viking Therapeutics, in development in both subcutaneous and oral forms for obesity. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Pramlintid or VK2735?: The highest available evidence level is "РКИ на людях" for Pramlintid and "РКИ на людях" for VK2735. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Pramlintid and VK2735 in Germany and the United States?: Германия: Pramlintid — Не одобрено, VK2735 — Не одобрено. США: Pramlintid — Рецептурный, VK2735 — Не одобрено. These are factual summaries with source and review date on the individual pages.

Country

Pramlintid

VK2735

Германия

Не одобрено

США

Рецептурный

Не одобрено

Frequently asked questions

What is the difference between Pramlintid and VK2735?

Pramlintid is classified as "Метаболизм", while VK2735 is classified as "Метаболизм". Pramlintid: Pramlintide is a synthetic analog of the hormone amylin. It is used as an adjunct to mealtime insulin therapy in type 1 and type 2 diabetes and, among other things, slows gastric emptying. VK2735: VK2735 is a dual GLP-1/GIP receptor agonist from Viking Therapeutics, in development in both subcutaneous and oral forms for obesity. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Pramlintid or VK2735?

The highest available evidence level is "РКИ на людях" for Pramlintid and "РКИ на людях" for VK2735. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Pramlintid and VK2735 in Germany and the United States?

Германия: Pramlintid — Не одобрено, VK2735 — Не одобрено. США: Pramlintid — Рецептурный, VK2735 — Не одобрено. These are factual summaries with source and review date on the individual pages.